1. Home
  2. VOR vs WNEB Comparison

VOR vs WNEB Comparison

Compare VOR & WNEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VOR
  • WNEB
  • Stock Information
  • Founded
  • VOR 2015
  • WNEB 1853
  • Country
  • VOR United States
  • WNEB United States
  • Employees
  • VOR N/A
  • WNEB N/A
  • Industry
  • VOR Biotechnology: Pharmaceutical Preparations
  • WNEB Savings Institutions
  • Sector
  • VOR Health Care
  • WNEB Finance
  • Exchange
  • VOR Nasdaq
  • WNEB Nasdaq
  • Market Cap
  • VOR 207.1M
  • WNEB 195.7M
  • IPO Year
  • VOR 2021
  • WNEB N/A
  • Fundamental
  • Price
  • VOR $29.40
  • WNEB $11.19
  • Analyst Decision
  • VOR Buy
  • WNEB Buy
  • Analyst Count
  • VOR 6
  • WNEB 2
  • Target Price
  • VOR $85.33
  • WNEB $11.00
  • AVG Volume (30 Days)
  • VOR 526.1K
  • WNEB 52.4K
  • Earning Date
  • VOR 11-06-2025
  • WNEB 10-22-2025
  • Dividend Yield
  • VOR N/A
  • WNEB 2.58%
  • EPS Growth
  • VOR N/A
  • WNEB N/A
  • EPS
  • VOR N/A
  • WNEB 0.59
  • Revenue
  • VOR N/A
  • WNEB $76,036,000.00
  • Revenue This Year
  • VOR N/A
  • WNEB N/A
  • Revenue Next Year
  • VOR N/A
  • WNEB $7.36
  • P/E Ratio
  • VOR N/A
  • WNEB $18.45
  • Revenue Growth
  • VOR N/A
  • WNEB 2.15
  • 52 Week Low
  • VOR $2.62
  • WNEB $7.63
  • 52 Week High
  • VOR $65.80
  • WNEB $12.80
  • Technical
  • Relative Strength Index (RSI)
  • VOR 52.41
  • WNEB 41.98
  • Support Level
  • VOR $28.65
  • WNEB $10.78
  • Resistance Level
  • VOR $31.31
  • WNEB $11.69
  • Average True Range (ATR)
  • VOR 3.26
  • WNEB 0.36
  • MACD
  • VOR -1.89
  • WNEB -0.08
  • Stochastic Oscillator
  • VOR 2.79
  • WNEB 29.23

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.

About WNEB Western New England Bancorp Inc.

Western New England Bancorp Inc through its bank subsidiary, provides a range of financial services to individuals and companies in western Massachusetts and northern Connecticut. These services include commercial lending, residential lending and consumer lending, checking, savings and time deposits, cash management, and wealth management. Substantially all of the company's revenues, profits, and assets are derived by the Bank from banking products and services.

Share on Social Networks: